FLXN Flexion Therapeutics Inc

Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that Michael Clayman, M.D., President and Chief Executive Officer, and Dan Deardorf, Senior Vice President, Commercial Operations, will participate in a fireside chat at Needham & Company's 17th Annual Healthcare Conference in New York City on Tuesday, March 27, 2018 at 10 a.m. ET. To access the live webcast and subsequent archived recording of the presentation, visit the Flexion website at http://ir.flexiontherapeutics.com.

About Flexion TherapeuticsFlexion Therapeutics (Nasdaq:FLXN) is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis, a type of degenerative arthritis. The company's core values are focus, ingenuity, tenacity, transparency and fun. Flexion was named one of The Boston Business Journal's 2017 Best Places to Work and one of the Top Places to Work in Massachusetts by The Boston Globe.

Contact:

Scott YoungVice President, Corporate Communications and Investor Relations Flexion Therapeutics, Inc.T: 781-305-7194syoung@flexiontherapeutics.com